Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$13,486,391
+$2,955,945 QoQ
Shares Held
11,244
-1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
6.82%
of 13F equity value
Holder Rank
#1,089
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 41%
Shared 58%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEOPLES FINANCIAL SERVICES CORP. holds $30,501,464 across 11 Drug Manufacturers - General names. LLY ranks #1 (44.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
11,244 | $13,486,391 | |
| 2 | JNJ |
Johnson & Johnson
|
19,251 | $4,889,175 | |
| 3 | ABBV |
AbbVie Inc.
|
18,482 | $4,650,810 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,170 | $2,848,845 | |
| 5 | AMGN |
Amgen Inc
|
4,453 | $1,612,520 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
26,066 | $1,501,922 | |
| 7 | PFE |
Pfizer Inc
|
36,641 | $882,314 | |
| 8 | NVS |
Novartis AG
|
1,703 | $266,893 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,486,391 | 11,244 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $10,530,446 | 11,449 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $13,115,395 | 12,204 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $9,520,714 | 12,478 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $9,836,888 | 12,619 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $10,908,618 | 13,208 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $10,367,960 | 13,430 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $12,153,324 | 13,718 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $14,327,637 | 15,825 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $12,669,078 | 16,285 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $9,929,459 | 17,034 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $9,209,093 | 17,145 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $7,966,562 | 16,987 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $5,937,731 | 17,290 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $6,398,907 | 17,491 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $5,657,654 | 17,497 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $5,712,931 | 17,620 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $4,882,894 | 17,051 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $4,856,223 | 17,581 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $3,891,112 | 16,841 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $3,850,427 | 16,776 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $3,142,498 | 16,821 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $2,907,593 | 17,221 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $2,489,843 | 16,821 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $2,773,984 | 16,896 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $2,204,260 | 15,890 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||